Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 332 followers

Latest posts

Last updated about 14 hours ago

Human medicines European public assessment report (EPAR): Optison, perflutren, Date of authorisation: 17/05/1998, Revision: 20, Status: Authorised

about 14 hours ago

Human medicines European public assessment report (EPAR): Optison, perflutren, Date of authorisation...

Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Date of authorisation: 16/02/2012, Revision: 31, Status: Authorised

about 14 hours ago

Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Date of authorisation...

Human medicines European public assessment report (EPAR): Eurneffy, epinephrine, Date of authorisation: 22/08/2024, Revision: 6, Status: Authorised

about 15 hours ago

Human medicines European public assessment report (EPAR): Eurneffy, epinephrine, Date of authorisation...

Human medicines European public assessment report (EPAR): Ozurdex, dexamethasone, Date of authorisation: 26/07/2010, Revision: 22, Status: Authorised

about 16 hours ago

Human medicines European public assessment report (EPAR): Ozurdex, dexamethasone, Date of authorisation...

Human medicines European public assessment report (EPAR): Vyepti, eptinezumab, Date of authorisation: 24/01/2022, Revision: 8, Status: Authorised

about 16 hours ago

Human medicines European public assessment report (EPAR): Vyepti, eptinezumab, Date of authorisation...

Emergency Task Force (ETF) recommendations

about 17 hours ago

Emergency Task Force (ETF) recommendations

Enpr-EMA priority activities

about 17 hours ago

Enpr-EMA priority activities

ETF recommends updating COVID-19 vaccines to target XFG variant

about 17 hours ago

ETF recommends updating COVID-19 vaccines to target XFG variant

EMA recommendation to update the antigenic composition of authorised COVID-19 vaccines for 2026-2027

about 17 hours ago

EMA recommendation to update the antigenic composition of authorised COVID-19 vaccines for...

Need for maximum residue limit (MRL) evaluation for biological substances - Scientific guideline

about 18 hours ago

Need for maximum residue limit (MRL) evaluation for biological substances - Scientific...

List of centrally authorised products with safety-related changes to the product information

about 18 hours ago

List of centrally authorised products with safety-related changes to the product information